000 | 00690nam a2200265Ia 4500 | ||
---|---|---|---|
003 | 00IHBT | ||
005 | 20140908102145.0 | ||
008 | 130910s9999 xx 000 0 und d | ||
020 | _a8.54046e+008 | ||
041 | _hENG | ||
080 | _a615.1 | ||
245 | _aMedicinal Chemistry: Principles and Practice | ||
250 | _a2nd | ||
260 |
_aOxford _bRoyal Society of Chemistry _c2002 |
||
300 | _axxvii, 448p. | ||
653 | _a Drug Metabolisms | ||
653 | _a Enzyme Inhibitors | ||
653 | _a Intracellular Targets | ||
653 | _a Ion Channels | ||
653 | _a Pharmacokinetics | ||
653 | _a Toxicology- Drug Discovery | ||
653 | _aDrug-Receptor Interactions | ||
942 | _2DDC | ||
942 | _cBK | ||
999 |
_c4176 _d4176 |
||
856 |
_uhttp://14.139.59.218:80/cgi-bin/koha/opac-detail.pl?biblionumber=4176 _yhttp://14.139.59.218:80/cgi-bin/koha/opac-detail.pl?biblionumber=4176 |